Riskpilot← Back to searchSign inGet full accessHobert Vårdkonsult AB
ABIn liquidationOrg 5593489320FalunHospital activities · NACE 8610Est. 20211 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
709700.0%
-102% vs 2023
Equity ratio
94.9%
Financial strength
Net profit 2024
SEK 42K
-87% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -7K | -102% |
| Net profit | SEK 42K | -87% |
| Total assets | SEK 213K | -64% |
| Equity | SEK 202K | -64% |
| Employees | 1 | — |
Legal name
Hobert Vårdkonsult AB
Org number
5593489320
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
26 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget ska bedriva konsultverksamhet och tillhandahålla och försälja tjänster inom vård och utbildning och därmed förenlig verksamhet. Bolaget skall även äga och förvalta värdepapper och annan lös och fast egendom.
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 576 | 451 | −0 |
| Staff expenses | −12 | −14 | −0 |
| EBITDA | 526 | 396 | −7 |
| Depreciation & amort. | — | — | — |
| EBIT | 526 | 396 | −7 |
| Net financials | — | 0 | 60 |
| Profit before tax | 526 | 396 | 53 |
| Tax | −108 | −82 | −11 |
| Net profit | 418 | 314 | 42 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 496 | 586 | 213 |
| Equity | 443 | 561 | 202 |
| Long-term debt | — | — | — |
| Short-term debt | 53 | 25 | 11 |
| Total debt | 53 | 25 | 11 |
EBITDA margin
-709700.0%
This company
15.8%
Market median
-4491872% vs market
20222024
Equity ratio
94.9%
This company
38.2%
Market median
+148% vs market
20222024
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
20222024
Net profit margin
4182800.0%
This company
8.1%
Market median
+51639406% vs market
20222024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LB External Signatory | External Signatory | 2025 |
BJ External Signatory | External Signatory | 2025 |
AE External Signatory | External Signatory | 2025 |
UM External Signatory | External Signatory | 2025 |
EJ Liquidator | Liquidator | 2025 |
| Former (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hobert Vårdkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Anna Kristin Hobert | Chief Executive Officer | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Anna Elisabet Viktoria Björk | External Signatory | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Emma Johanna Karin Carlstedt Haga | Liquidator | 0 companies |
| Per Gunnar Wilhelm Sautermeister | Deputy Board Member | 0 companies |